Market View

The U.S. market was shifted to an Uptrend Under Pressure. The S&P 500 and Nasdaq declined 1.9% and 3.6%, respectively, with each index closing below its 21-DMA (5,533 ,18,002). The next level of support it the rising 50-DMA (5,410;17,422), which is ~2% lower. The distribution day stands at five and four, respectively, with one day expiring on each index at the end of next week.

Market View

The U.S. market remains in a Confirmed Uptrend. This week, the S&P 500 was up 0.9%, while Nasdaq was up 0.3%. Both pushed further into all-time highs but finished in the bottom half of the weekly range. Immediate support is at the rising 10-DMA (5,553/18,234), with the next level of support at the rising 21-DMA (5,504/17,957). The distribution day count stands at three on both indices.

O’Neil Health Care Weekly

XLV declined 92 bps last week and is testing support at its 50-DMA ($144.26). It breached its 21-DMA ($145.26). Its RS line remains in
a long-term downtrend, warranting an underweight sector positioning. We will be looking for the sector to break into new highs
before recommending an overweight sector positioning.

Market View

The U.S. market remains in a Confirmed Uptrend. This week, the S&P 500 rose 1.9%, while the Nasdaq gained 3.5% this week and both indices pushed back into all-time highs. Immediate support at rising 10-DMAs (5,489/17,875), with the next level of support at rising 21-DMAs (5,446/17,668). The distribution day count stands at two on both the indices after one expired due to time at the end of the week.

O’Neil Health Care Weekly

XLV declined 72 bps last week, still holding support at its rising 21-DMA ($145.86) with next support at its 100-DMA ($144.29).
Resistance is at $147.16 before all-time highs of $148.27. Though Health Care is the second best performing sector behind
Technology over the trailing 8-weeks, its RS line remains in a long-term downtrend, still warranting an equal-to-underweight sector
positioning. We will be looking for the sector to break into new highs before recommending an overweight sector positioning.

Market View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 was essentially flat this week while the Nasdaq rose ~20 bps. Indices are just below all-time highs and are testing 10-DMA support (5,454/17,681) after staging a downside reversal on Friday. The next level of support is at the rising  21-DMA (5,409/17,453) which is 1-2% lower. The distribution day count stands at three and four, respectively.

O’Neil Health Care Weekly

XLV gained 64bps last week holding support at its rising 21-DMA ($145.43). Resistance is at $147.16 before all-time highs of $148.27. Though Health Care is the third best performing sector behind Technology and Retail over the trailing 4-weeks, its RS line remains in a long-term downtrend, still warranting an equal-to-underweight sector positioning. We will be looking for the sector to break into new highs before recommending an overweight sector positioning.

Market View

The U.S. market remains in a Confirmed Uptrend. Indices remain near all-time highs with the first level of support at the rising 10-DMA (5,429/17,572), followed by the 21-DMA (5,373/17,242). The distribution day count stands at four on each index with one and two days set to expire on the S&P 500 and Nasdaq, respectively, next week.